You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
凱普生物(300639.SZ)前三季度淨利預增123.20%-145.16%
格隆匯 09-06 15:55

格隆匯9月6日丨凱普生物(300639.SZ)披露2021年前三季度業績預吿,預計2021年1-9月實現歸屬於上市公司股東的淨利潤6.10億元-6.70億元,同比增長123.20%-145.16%;預計2021年7-9月實現歸屬於上市公司股東的淨利潤2.19億元-2.79億元,同比增長51.74%-93.32%。業績變動原因説明:

1.報吿期內,公司經營管理層認真落實董事會制定的2021年度經營計劃,持續踐行“核酸99”戰略,適時推出“凱普B53核酸遠程戰略服務方案”,持續加大研發創新投入,加強市場拓展,加強團隊建設和人員培養,提升整體服務能力和技術水平,促使公司業務取得較快增長。報吿期內,公司持續關注疫情發展動態,以集團作戰模式持續參與香港及內地新冠疫情防控,相關業務獲得快速發展。

2.報吿期內,預計非經常性損益對公司淨利潤的影響金額約為1508.00萬元,對報吿期盈利沒有重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account